Why the study?
Does plasma PAPP-A level predict future death, ACS, and revascularization in patients with chronic stable CAD?
Population
103 patients referred for coronary angiography with chronic stable coronary artery disease, mean age 65+/-10…
Design
Cohort
Follow-up
median 4.9 years
Authors
Loading...
May refine prognosis in stable CAD; hypothesis-generating and requires prospective validation before clinical use.
Does plasma PAPP-A level predict future death, ACS, and revascularization in patients with chronic stable CAD?
Elevated plasma PAPP-A levels independently predict the occurrence of death and acute coronary syndrome in patients with chronic stable coronary artery disease.
Ahmad A. Elesber (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: